← Back to catalogue

Relivion

FDA UDI

Class II (US FDA UDI)

by Neurolief , Ltd.

Identity

Trade Name
Relivion FDA UDI
Generic Name
Craniofacial analgesia electrical stimulator FDA UDI
Device Name
Relivion is a non-invasive medical device. It transfers mild electrical pulses to branches of the Trigeminal (Supraorbital and Supratrochlear) and Occipital nerves to treat headaches. FDA UDI
Model / Reference
RLV3 FDA UDI
Description
Relivion is a non-invasive medical device. It transfers mild electrical pulses to branches of the Trigeminal (Supraorbital and Supratrochlear) and Occipital nerves to treat headaches. FDA UDI

Identifiers

Primary DI / UDI-DI
07290018393000 FDA UDI
510(k) Number
K212106 FDA UDI
FDA Product Code
PCC FDA UDI
GMDN Term
Craniofacial analgesia electrical stimulator FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
882.5891 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Craniofacial analgesia electrical stimulator

Relivion by Neurolief , Ltd. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Craniofacial analgesia electrical stimulator.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Neurolief , Ltd.

Sources (1)

  • FDA UDI b57991af-8a4e-488d-8ad7-410c90abed04 34 fields · synced Jun 6, 2026